{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:08:00Z","timestamp":1770044880228,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI111466"],"award-info":[{"award-number":["AI111466"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.actbio.2019.10.016","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T20:17:53Z","timestamp":1570825073000},"page":"326-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague"],"prefix":"10.1016","volume":"100","author":[{"given":"Danielle A","family":"Wagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean M","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Peroutka-Bigus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross J","family":"Darling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4034-6482","authenticated-orcid":false,"given":"Bryan H","family":"Bellaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4534-9452","authenticated-orcid":false,"given":"Michael J","family":"Wannemuehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-5353","authenticated-orcid":false,"given":"Balaji","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2019.10.016_bib0001","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tim.2015.11.008","article-title":"Pneumonic plague: the darker side of Yersinia pestis","volume":"24","author":"Pechous","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.actbio.2019.10.016_bib0002","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/08998280.2005.11928049","article-title":"Plague: from natural disease to bioterrorism","volume":"18","author":"Riedel","year":"2005","journal-title":"Baylor Univ. Med. Cent. Proc."},{"key":"10.1016\/j.actbio.2019.10.016_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2013.00106","article-title":"Yersinia pestis: mechanisms of entry into and resistance to the host cell","volume":"3","author":"Ke","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.actbio.2019.10.016_bib0004","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"for the working group on civilian biodefense, plague as a biological weapon","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.actbio.2019.10.016_bib0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An igg1 titre to the F1 and v antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.actbio.2019.10.016_bib0006","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1128\/CVI.00013-14","article-title":"Direct neutralization of type iii effector translocation by the variable region of a monoclonal antibody to Yersinia pestis lcrv","volume":"21","author":"Ivanov","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.actbio.2019.10.016_bib0007","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/iai.65.11.4476-4482.1997","article-title":"Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization","volume":"65","author":"Hill","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actbio.2019.10.016_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0013047","article-title":"Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model","volume":"5","author":"Xiao","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2019.10.016_bib0009","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/IAI.71.4.2234-2238.2003","article-title":"Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and v antigens of Yersinia pestis","volume":"71","author":"Hill","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actbio.2019.10.016_bib0010","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.10.016_bib0011","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pep.2006.12.018","article-title":"Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague","volume":"53","author":"Goodin","year":"2007","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.actbio.2019.10.016_bib0012","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"Powell","year":"2005","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.actbio.2019.10.016_bib0013","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1016\/j.vaccine.2011.06.119","article-title":"Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines","volume":"29","author":"Quenee","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.10.016_bib0014","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.chom.2016.01.010","article-title":"The cGAS-STING defense pathway and its counteraction by viruses","volume":"19","author":"Ma","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.actbio.2019.10.016_bib0015","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.cell.2013.08.014","article-title":"Cyclic dinucleotides and the innate immune response","volume":"154","author":"Danilchanka","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2019.10.016_bib0016","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2019.10.016_bib0017","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrmicro.2016.190","article-title":"Cyclic di-GMP: second messenger extraordinaire","volume":"15","author":"Jenal","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.actbio.2019.10.016_bib0018","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.vaccine.2006.10.033","article-title":"The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties","volume":"25","author":"Ebensen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.10.016_bib0019","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2009.04.053","article-title":"c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection","volume":"27","author":"Hu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.10.016_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-bioeng-082615-030519","article-title":"Rational design of targeted next-generation carriers for drug and vaccine delivery","volume":"18","author":"Narasimhan","year":"2016","journal-title":"Annu Rev Biomed Eng."},{"key":"10.1016\/j.actbio.2019.10.016_bib0021","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/adhm.201200181","article-title":"Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery","volume":"2","author":"Huntimer","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2019.10.016_bib0022","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1208\/s12248-014-9699-z","article-title":"Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles","volume":"17","author":"Vela-Ramirez","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.actbio.2019.10.016_bib0023","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0169-409X(02)00050-9","article-title":"Polyanhydrides: an overview","volume":"54","author":"Kumar","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2019.10.016_bib0024","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1016\/j.actbio.2010.01.040","article-title":"Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens","volume":"6","author":"Carrillo-Conde","year":"2010","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.10.016_bib0025","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1021\/mp2004059","article-title":"Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen","volume":"9","author":"Petersen","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2019.10.016_bib0026","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1080\/09205063.2014.940243","article-title":"Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells","volume":"25","author":"Vela Ramirez","year":"2014","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.actbio.2019.10.016_bib0027","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jbm.b.32820","article-title":"Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses","volume":"101","author":"Huntimer","year":"2013","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.actbio.2019.10.016_bib0028","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jbm.a.30510","article-title":"Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms","volume":"76","author":"Torres","year":"2006","journal-title":"J. Biomed. Mater. Res. - Part A."},{"key":"10.1016\/j.actbio.2019.10.016_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0017642","article-title":"Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases","volume":"6","author":"Ulery","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2019.10.016_bib0030","doi-asserted-by":"crossref","first-page":"13770","DOI":"10.1039\/C4NR03724C","article-title":"Effect of nanovaccine chemistry on humoral immune response kinetics and maturation","volume":"6","author":"Haughney","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.actbio.2019.10.016_bib0031","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1016\/S0142-9612(02)00181-3","article-title":"Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery","volume":"23","author":"Kipper","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.10.016_bib0032","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1016\/j.biomaterials.2011.05.063","article-title":"Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants","volume":"32","author":"Petersen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.10.016_bib0033","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/j.actbio.2011.03.023","article-title":"Polyanhydride microparticles enhance dendritic cell antigen presentation and activation","volume":"7","author":"Torres","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.10.016_bib0034","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1016\/j.biomaterials.2009.05.069","article-title":"The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells","volume":"30","author":"Petersen","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.10.016_bib0035","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/jbm.a.30545","article-title":"Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism","volume":"76","author":"Kipper","year":"2006","journal-title":"J. Biomed. Mater. Res. - Part A"},{"key":"10.1016\/j.actbio.2019.10.016_bib0036","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11095-008-9760-7","article-title":"Polymer chemistry influences monocytic uptake of polyanhydride nanospheres","volume":"26","author":"Ulery","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2019.10.016_bib0037","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/srep00198","article-title":"Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants","volume":"1","author":"Ulery","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2019.10.016_bib0038","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/ppsc.201400148","article-title":"Nanoparticle chemistry and functionalization differentially regulates dendritic cell-nanoparticle interactions and triggers dendritic cell maturation","volume":"31","author":"Goodman","year":"2014","journal-title":"Part. Part. Syst. Charact."},{"key":"10.1016\/j.actbio.2019.10.016_bib0039","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1016\/j.actbio.2013.06.024","article-title":"Functionalization of polyanhydride microparticles with di-mannose influences uptake by and intracellular fate within dendritic cells","volume":"9","author":"Phanse","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.10.016_bib0040","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1016\/j.actbio.2012.06.001","article-title":"Chemistry-dependent adsorption of serum proteins onto polyanhydride microparticles differentially influences dendritic cell uptake and activation","volume":"8","author":"Carrillo-Conde","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.10.016_bib0041","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1016\/j.biomaterials.2012.03.027","article-title":"Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using \u201cpathogen-like\u201d amphiphilic polyanhydride nanoparticles","volume":"33","author":"Chavez-Santoscoy","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.10.016_bib0042","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1021\/mp200213r","article-title":"Mannose-functionalized \u201cpathogen-like\u201d polyanhydride nanoparticles target C-type lectin receptors on dendritic cells","volume":"8","author":"Carrillo-Conde","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2019.10.016_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00325","article-title":"Room temperature stable PspA-based nanovaccine induces protective immunity","volume":"9","author":"Wagner-Mu\u00f1iz","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2019.10.016_bib0044","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1021\/acsbiomaterials.5b00477","article-title":"Combination nanovaccine demonstrates synergistic enhancement in efficacy against influenza","volume":"2","author":"Ross","year":"2016","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.actbio.2019.10.016_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1004142","article-title":"TNF\u03b1 and IFN\u03b3 but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection","volume":"10","author":"Szaba","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.actbio.2019.10.016_bib0046","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.vaccine.2010.08.099","article-title":"TNF\u03b1 and IFN\u03b3 contribute to F1\/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague","volume":"29","author":"Lin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.10.016_bib0047","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates","volume":"16","author":"Mizel","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.actbio.2019.10.016_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00687","article-title":"A bivalent anthrax\u2013plague vaccine that can protect against two tier-1 bioterror pathogens, Bacillus anthracis and Yersinia pestis","volume":"8","author":"Tao","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2019.10.016_bib0049","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.10.016_bib0050","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.vaccine.2006.09.052","article-title":"Kinetics of the immune response to the (F1\u202f+\u202fV) vaccine in models of bubonic and pneumonic plague","volume":"25","author":"Williamson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.10.016_bib0051","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.1998.58.793","article-title":"Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice","volume":"58","author":"Anderson","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actbio.2019.10.016_bib0052","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1128\/CVI.05559-11","article-title":"Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients","volume":"19","author":"Li","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.actbio.2019.10.016_bib0053","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.vaccine.2005.11.047","article-title":"Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague","volume":"24","author":"Reed","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.10.016_bib0054","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/IAI.74.5.3068-3070.2006","article-title":"Administration of antibody to the lung protects mice against pneumonic plague","volume":"74","author":"Hill","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actbio.2019.10.016_bib0055","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.vaccine.2004.10.025","article-title":"Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens","volume":"23","author":"Glynn","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.10.016_bib0056","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1016\/j.vaccine.2007.09.030","article-title":"Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens","volume":"25","author":"Uddowla","year":"2007","journal-title":"Vaccine"},{"issue":"2015","key":"10.1016\/j.actbio.2019.10.016_bib0057","first-page":"1","article-title":"The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo","author":"Blaauboer","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.actbio.2019.10.016_bib0058","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4049\/jimmunol.178.4.2171","article-title":"Bacterial c-di-GMP is an immunostimulatory molecule.","volume":"178","author":"Karaolis","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2019.10.016_bib0059","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.vaccine.2009.11.076","article-title":"Amino acid residues 196\u2013225 of LcrV represent a plague protective epitope","volume":"28","author":"Quenee","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.10.016_bib0060","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.vaccine.2007.11.028","article-title":"Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis","volume":"26","author":"Khan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.10.016_bib0061","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1038\/srep03775","article-title":"A systems approach to designing next generation vaccines: combining \u03b1-galactose modified antigens with nanoparticle platforms","volume":"4","author":"Phanse","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2019.10.016_bib0062","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1128\/IAI.00273-09","article-title":"D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague","volume":"77","author":"Szaba","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actbio.2019.10.016_bib0063","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actbio.2019.10.016_bib0064","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.01529-06","article-title":"Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection","volume":"75","author":"Philipovskiy","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actbio.2019.10.016_bib0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/CVI.00398-06","article-title":"Development of in vitro correlate assays of immunity to infection with Yersinia pestis","volume":"14","author":"Bashaw","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.actbio.2019.10.016_bib0066","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.actbio.2019.10.016_bib0067","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1142\/S2339547814500162","article-title":"Polyanhydride nanovaccine platform enhances antigen-specific cytotoxic T cell responses","volume":"2","author":"Huntimer","year":"2014","journal-title":"Technology"},{"key":"10.1016\/j.actbio.2019.10.016_bib0068","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/02652040601033841","article-title":"The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres.","volume":"23","author":"Determan","year":"2006","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.actbio.2019.10.016_bib0069","first-page":"229","article-title":"Hemagglutinin-based polyanhydride nanovaccines against H5N1 infuenza elicit protective virus neutralizing titers and cell-mediated immunity","volume":"10","author":"Ross","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2019.10.016_bib0070","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1016\/j.actbio.2013.06.006","article-title":"Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles","volume":"9","author":"Haughney","year":"2013","journal-title":"Acta Biomater."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119306920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119306920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:22:36Z","timestamp":1761672156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706119306920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":70,"alternative-id":["S1742706119306920"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2019.10.016","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2019.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}